With milestone-linked funding of Rs. 5–25 crore per project (and up to Rs. 50 crore in exceptional cases), the Mission will support projects that bring impactful MedTech solutions to market
Agreement adds a new preclinical ADC with potential for enhanced anti-tumour activity and best-in-class profile
Telangana aims to increase the value of the Life Sciences economy from US$ 80 billion to US$ 250 billion by 2030
The acquisition centers on ImCheck’s lead Phase I/II program, ICT01, a first-in-class monoclonal antibody targeting BTN3A
The expansion underscores Merck’s commitment to invest more than $70 billion in U.S. research, development and capital projects
The new data highlight the potential of AstraZeneca’s innovative therapies to improve outcomes across multiple cancer types
Expanded capabilities that continue to push the boundaries of innovation—advancing drug delivery solutions for patients, customers, and consumers around the world
Hengrui is eligible to receive regulatory and commercial milestone payments of up to US$1.093 billion
Merck opens first climate-neutral manufacturing facility in Ireland
This marks the first of four new U.S. manufacturing sites that Lilly plans to announce this year
Subscribe To Our Newsletter & Stay Updated
